Stocks › OGN

Organon & Co.

OGN·NYSE·United States United States·USD
$13.89
-0.02 (-0.14%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
OGN
Organon & Co. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
OGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of OGN by members of U.S. Congress · 28 on record · 3 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Kevin HernKevin HernHouse · R · OK OGNOrganon & Co. · Stock Sale
$1,001 - $15,000
Aug 12, 2026 Aug 5, 2026 Filing ↗
Kevin HernKevin HernHouse · R · OK OGNOrganon & Co. · Stock Sale
$1,001 - $15,000
Aug 10, 2026 Aug 5, 2026 Filing ↗
Gary C. PetersGary C. PetersSenate · D · MI OGNOrganon & Co. · Stock Sale
$1,001 - $15,000
Nov 24, 2025 Jul 10, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Sale
$1,001 - $15,000
Jan 4, 2024 Dec 4, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Sale
$1,001 - $15,000
Dec 6, 2023 Nov 3, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Purchase
$1,001 - $15,000
Nov 8, 2023 Oct 2, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Sale
$1,001 - $15,000
Aug 7, 2023 Jul 28, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Purchase
$1,001 - $15,000
Jul 11, 2023 Jun 29, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Purchase
$1,001 - $15,000
Jun 12, 2023 May 19, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Stock Sale
$1,001 - $15,000
May 8, 2023 Apr 25, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA OGNOrganon & Co. · Common Stock Purchase
$1,001 - $15,000
Apr 7, 2023 Mar 14, 2023 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Sale
$50,001 - $100,000
Jan 27, 2022 Dec 23, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Sale
$15,001 - $50,000
Jan 27, 2022 Dec 23, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$250,001 - $500,000
Sep 29, 2021 Aug 16, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Sep 29, 2021 Aug 16, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Aug 18, 2021 Jul 8, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Aug 18, 2021 Jul 8, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$15,001 - $50,000
Aug 18, 2021 Jul 7, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Aug 18, 2021 Jul 7, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Jul 16, 2021 Jun 21, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$15,001 - $50,000
Jul 16, 2021 Jun 11, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$15,001 - $50,000
Jul 16, 2021 Jun 17, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$1,001 - $15,000
Jul 16, 2021 Jun 21, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$100,001 - $250,000
Jul 16, 2021 Jun 11, 2021 Filing ↗
Michael T. McCaulMichael T. McCaulHouse · R · TX OGNOrganon & Co. · Stock Purchase
$50,001 - $100,000
Jul 16, 2021 Jun 17, 2021 Filing ↗

Whale Activity

Position changes in OGN reported for 2026-09-30 by 666 institutional filers
Increased: 147New: 47Held: 187Decreased: 181Closed: 66No prior filing: 38
  • Increased147
  • New47
  • Held187
  • Decreased181
  • Closed66
  • No prior filing38
FilerSharesValueChange
BlackRock, Inc.31.9M$437.3Mdecreased
Pentwater Capital Management LP20.2M$276.5Mincreased
VANGUARD PORTFOLIO MANAGEMENT LLC15.4M$210.3Mincreased
VANGUARD CAPITAL MANAGEMENT LLC11.9M$163.3Mincreased
FIL Ltd10.5M$143.9Mnew
STATE STREET CORP9.8M$133.7Mincreased
MILLENNIUM MANAGEMENT LLC5.1M$70.4Mincreased
ALLIANCEBERNSTEIN L.P.4.8M$65.9Mincreased
Man Group plc4.8M$65.9Mincreased
GEODE CAPITAL MANAGEMENT, LLC4.6M$63.6Mdecreased
UBS Group AG4.5M$61.0Mdecreased
NEXPOINT ASSET MANAGEMENT, L.P.4.4M$60.3Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by OGN insiders, by quarter · Form 4
-100.0K-50.0K050.0K100.0K2025 Q1: 02025 Q12025 Q2: 74.9K2025 Q22025 Q3: 02025 Q32025 Q4: 65.4K2025 Q42026 Q1: 02026 Q12026 Q2: 26.4K2026 Q22026 Q3: -14.8K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

446 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Arjona Ferreira Juan CamiloHead of R&D & CMO Tax withholding −4,134 $13.62 $56K Aug 11, 2026 Form 4 ↗
Arjona Ferreira Juan CamiloHead of R&D & CMO Option exercise +11.5K $0.00 $0 Aug 11, 2026 Form 4 ↗
Drinane Juliana PapaHead of Mfg & Supply Sale −14.8K $13.57 $200K Aug 5, 2026 Form 4 ↗
Holzbaur LynetteSVP and Corporate Controller Sale Amended −26.4K $13.35 $353K May 6, 2026 Form 4 ↗
Holzbaur LynetteSVP and Corporate Controller Other Amended +46 $0.00 $0 May 6, 2026 Form 4 ↗
Holzbaur LynetteSVP and Corporate Controller Purchase +26.4K $13.35 $353K May 6, 2026 Form 4 ↗
Drinane Juliana PapaInterim Head of Mfg & Supply Tax withholding −3,451 $5.70 $20K Mar 31, 2026 Form 4 ↗
Drinane Juliana PapaInterim Head of Mfg & Supply Option exercise +10.1K $0.00 $0 Mar 31, 2026 Form 4 ↗
Drinane Juliana PapaInterim Head of Mfg & Supply Tax withholding −2,185 $5.70 $12K Mar 31, 2026 Form 4 ↗
Drinane Juliana PapaInterim Head of Mfg & Supply Option exercise +6,378 $0.00 $0 Mar 31, 2026 Form 4 ↗
Arjona Ferreira Juan CamiloHead of R&D & CMO Tax withholding −4,820 $5.70 $27K Mar 31, 2026 Form 4 ↗
Arjona Ferreira Juan CamiloHead of R&D & CMO Option exercise +13.4K $0.00 $0 Mar 31, 2026 Form 4 ↗
Karp DanielExecutive VP, Corp. Dev. Tax withholding −2,105 $5.70 $12K Mar 31, 2026 Form 4 ↗
Karp DanielExecutive VP, Corp. Dev. Option exercise +6,715 $0.00 $0 Mar 31, 2026 Form 4 ↗
Karp DanielExecutive VP, Corp. Dev. Tax withholding −3,554 $5.70 $20K Mar 31, 2026 Form 4 ↗
Karp DanielExecutive VP, Corp. Dev. Option exercise +11.3K $0.00 $0 Mar 31, 2026 Form 4 ↗
Stahler Rachel AChief Information Officer Tax withholding −4,217 $5.70 $24K Mar 31, 2026 Form 4 ↗
Stahler Rachel AChief Information Officer Option exercise +12.3K $0.00 $0 Mar 31, 2026 Form 4 ↗
Stahler Rachel AChief Information Officer Tax withholding −2,246 $5.70 $13K Mar 31, 2026 Form 4 ↗
Stahler Rachel AChief Information Officer Option exercise +6,555 $0.00 $0 Mar 31, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding OGN · SEC Form N-PORT
FundSharesValue% of fundAs of
iShares Core S&P Small-Cap ETF
iShares Trust
15.8M$214.2M0.19%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
8.3M$112.8M0.00%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
6.0M$81.6M0.04%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
3.8M$51.7M0.08%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
3.0M$40.8M0.04%Jun 30, 2026
Nexpoint Merger Arbitrage Fund
NexPoint Funds I
2.7M$36.6M2.46%Jun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF
SPDR SERIES TRUST
2.4M$32.7M0.19%Jun 30, 2026
iShares S&P Small-Cap 600 Value ETF
iShares Trust
2.3M$30.6M0.38%Jun 30, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF
SPDR SERIES TRUST
1.4M$18.5M0.38%Jun 30, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
1.3M$17.6M0.04%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list OGN's shares (CUSIP 68622V106), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Matthew HalbowerSCHEDULE 13G · passive (13G) · 18.1M shares6.9%
    Aug 14, 2026 · ↗
  • Pentwater Capital Management LPSCHEDULE 13G · passive (13G) · 18.1M shares6.9%
    Aug 14, 2026 · ↗
  • Vanguard Portfolio ManagementSCHEDULE 13G/A · passive (13G) · 15.2M shares5.8%
    Jul 31, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming organon as client
$0$625K$1.3M$1.9M$2.5M2023 Q1: $455K2023 Q2: $525K2023 Q3: $395K2023 Q4: $635K20232024 Q1: $485K2024 Q2: $335K2024 Q3: $485K2024 Q4: $450K20242025 Q1: $395K2025 Q2: $395K2025 Q3: $395K2025 Q4: $395K20252026 Q1: $435K2026 Q2: $435K2026 Q3: $455K2026
  • WILLIAMS AND JENSEN, PLLCORGANON · 2026 Q3 · HCR, BUD$50K
    Filing ↗
  • ORGANON & CO.ORGANON & CO. · 2026 Q3 · BUD, HCR, MMM$340K
    Filing ↗
  • TIBER CREEK GROUPORGANON, LLC · 2026 Q3 · HCR, BUD, MMM$60K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.ORGANON & CO. · 2026 Q3 · HCR, MMM$5K
    Filing ↗
  • WILLIAMS AND JENSEN, PLLCORGANON · 2026 Q2 · BUD, HCR$50K
    Filing ↗

Government Contracts

Federal awards to Organon & Co. · USAspending

No federal contract awards found for Organon & Co..

U.S. Patents

Recent USPTO applications naming Organon & Co.

No USPTO patent applications found for Organon & Co..

Annual Financials

From OGN's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$6.22B$6.40B$6.26B$6.17B$6.30B
Net income$187.0M$864.0M$1.02B$917.0M$1.35B
Diluted EPS$0.72$3.33$3.99$3.59$5.31
Operating cash flow$700.0M$939.0M$799.0M$858.0Mn/a
Cash and equivalents$574.0M$675.0M$693.0M$706.0M$737.0M
Total assets$12.87B$13.10B$12.06B$10.96B$10.68B
Total liabilities$12.12B$12.63B$12.13B$11.85Bn/a
Shareholders' equity$752.0M$472.0M-$70.0M-$892.0M-$1.51B

As Organon & Co. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in OGN's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 7.01, 9.01Reg FD disclosureOct 30, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureJul 31, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJul 23, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsJul 17, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 5.07, 9.01Officer / director change · Shareholder voteJun 11, 2026
    EDGAR ↗

About Organon & Co.

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersJERSEY CITY, NJ